Cold & Cough Remedies (Pharmacies) - Myanmar

  • Myanmar
  • Revenue in the Cold & Cough Remedies market is projected to reach US$47.17m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.91%, resulting in a market volume of US$69.01m by 2029.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.86 are generated in 2024.

Key regions: Canada, United Kingdom, United States, China, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Myanmar is experiencing significant growth, driven by changing customer preferences, emerging trends, and local special circumstances.

Customer preferences:
In Myanmar, there is a growing demand for Cold & Cough Remedies (Pharmacies) as customers increasingly prioritize their health and well-being. As the country undergoes rapid urbanization and modernization, individuals are becoming more aware of the importance of managing common illnesses such as cold and cough. This has led to an increased willingness to seek remedies from pharmacies to alleviate symptoms and promote faster recovery.

Trends in the market:
One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Myanmar is the shift towards natural and herbal remedies. Customers are increasingly opting for products that are perceived to be more natural and have fewer side effects. This trend is in line with the global movement towards holistic and alternative medicine. As a result, pharmacies in Myanmar are expanding their offerings to include a wider range of natural remedies, such as herbal teas and traditional medicines, to cater to this growing customer preference. Another trend in the market is the increasing availability of over-the-counter (OTC) medications. Previously, customers in Myanmar had limited access to OTC cold and cough remedies, as these products were mainly available through prescription. However, with the liberalization of regulations and the establishment of more modern pharmacies, OTC medications are now more easily accessible. This has led to a greater convenience for customers, who can now purchase these remedies without having to visit a healthcare professional.

Local special circumstances:
Myanmar's healthcare system is still developing, with limited access to healthcare facilities in rural areas. As a result, pharmacies play a crucial role in providing healthcare services and products to the population. The availability of Cold & Cough Remedies (Pharmacies) in these areas is particularly important, as it allows individuals to manage their symptoms and seek relief without having to travel long distances to see a doctor. This has contributed to the growth of the market, as pharmacies become a trusted source of healthcare for many people in Myanmar.

Underlying macroeconomic factors:
The economic growth and rising disposable income in Myanmar have also contributed to the development of the Cold & Cough Remedies (Pharmacies) market. As individuals have more purchasing power, they are able to afford healthcare products and are willing to spend on remedies to alleviate their cold and cough symptoms. The increasing urbanization and modernization of the country have also led to greater awareness and acceptance of Western medicine, further driving the demand for Cold & Cough Remedies (Pharmacies). In conclusion, the Cold & Cough Remedies (Pharmacies) market in Myanmar is experiencing growth due to changing customer preferences, emerging trends, and local special circumstances. The shift towards natural and herbal remedies, the availability of OTC medications, and the role of pharmacies in providing healthcare services in rural areas are all contributing factors. Additionally, the country's economic growth and rising disposable income have further fueled the demand for these remedies. As the market continues to develop, it is expected that pharmacies in Myanmar will continue to play a crucial role in meeting the healthcare needs of the population.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)